FDA recall, , Moderate risk
Camber Lacosamide Tablets
Lacosamide Tablets may contain a foreign tablet, Selexipag 1000 mcg.
Summary by Recall Canary from the FDA notice
What happened
Annora Pharma Private Limited of Hyderabad, India, recalled Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottles, distributed nationwide in the USA, because a complaint reported a possible mix-up of a Selexipag 1000 mcg tablet in a bottle of the product. The recall began on June 4, 2026, and was added to the FDA's Enforcement Report on June 24, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is your bottle affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle
- NDC
- 31722-813-60
- Lot code
- A253999
- A254000
Recall details
- Company began the recall
- Sold in
Nationwide in the USA
- Company
- Annora Pharma Private LimitedHyderabad, India
- Hazard
- Foreign object
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99200
- Recall number
- D-0626-2026
All recalls from Annora Pharma Private Limited
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
